Usa covid-19 testing vaccine prevention Usa

Phase 3 trial for Moderna COVID-19 vaccine begins amid US summer surge

Reading now: 889
www.cidrap.umn.edu

Today marks the start of the phase 3 trial of Moderna's  COVID-19 vaccine candidate. The COVE trial (Coronavirus Efficacy) will enroll 30,000 people at 89 sites across the country, with half the recipients receiving two shots of the vaccine 28 days apart, and the other half receiving placebos.

The study is blinded.According to Moderna, the primary endpoint will be the prevention of symptomatic COVID-19 disease, and secondary endpoints will include prevention of severe COVID-19 disease (as defined by the need for hospitalization) and prevention of infection by SARS-CoV-2, the virus that causes COVID-19, regardless of symptoms.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA